COL17A1 and diabetes mellitus: To define which BP180 regions these autoantibodies recognize, we compared sera from anti-BP180(+) patients with DM + DPP4i identified in that study to anti-BP180(−) patients with DM + DPP4i (Fig. 7 and table S8).